Crinetics Pharmaceuticals, Inc. Shareholders' Equity
Crinetics Pharmaceuticals, Inc. (CRNX) had Shareholders' Equity of $1.19 billion as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-03
- 2026-06-30: Stockholders' Equity Attributable to Parent $1.19B.
- 2026-03-31: Stockholders' Equity Attributable to Parent $1.28B.
- 2025-12-31: Stockholders' Equity Attributable to Parent $992.08M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $1.07B.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $1.19B 10-Q · filed 2026-08-03 |
| 2026-03-31 | $1.28B 10-Q · filed 2026-08-03 |
| 2025-12-31 | $992.08M 10-Q · filed 2026-08-03 |
| 2025-09-30 | $1.07B 10-Q · filed 2025-11-06 |
| 2025-06-30 | $1.17B 10-Q · filed 2026-08-03 |
| 2025-03-31 | $1.25B 10-Q · filed 2026-08-03 |
| 2024-12-31 | $1.32B 10-Q · filed 2026-08-03 |
| 2024-09-30 | $832.98M 10-Q · filed 2025-11-06 |
| 2024-06-30 | $830.76M 10-Q · filed 2025-11-06 |
| 2024-03-31 | $874.93M 10-Q · filed 2025-08-07 |
| 2023-12-31 | $539.11M 10-K · filed 2026-02-26 |
| 2023-09-30 | $547.75M 10-Q · filed 2024-11-12 |
| 2023-06-30 | $254.12M 10-Q · filed 2024-11-12 |
| 2023-03-31 | $280.33M 10-Q · filed 2024-08-08 |
| 2022-12-31 | $316.33M 10-K · filed 2026-02-26 |
| 2022-09-30 | $351.37M 10-Q · filed 2023-11-07 |
| 2022-06-30 | $386.17M 10-Q · filed 2023-11-07 |
| 2022-03-31 | $303.04M 10-Q · filed 2023-08-08 |
| 2021-12-31 | $331.94M 10-K · filed 2025-02-27 |
| 2021-09-30 | $193.59M 10-Q · filed 2022-11-14 |
| 2021-06-30 | $201.44M 10-Q · filed 2022-11-14 |
| 2021-03-31 | $149.48M 10-Q · filed 2022-08-12 |
| 2020-12-31 | $168.92M 10-K · filed 2024-02-28 |
| 2020-09-30 | $187.22M 10-Q · filed 2021-11-05 |
| 2020-06-30 | $202.77M 10-Q · filed 2021-11-05 |
| 2020-03-31 | $108.44M 10-Q · filed 2021-08-10 |
| 2019-12-31 | $117.14M 10-K · filed 2023-02-28 |
| 2019-09-30 | $129.52M 10-Q · filed 2020-11-06 |
| 2019-06-30 | $142.10M 10-Q · filed 2020-11-06 |
| 2019-03-31 | $152.39M 10-Q · filed 2020-08-07 |
| 2018-12-31 | $160.22M 10-K · filed 2022-03-30 |
| 2018-09-30 | $167.52M 10-Q · filed 2019-11-12 |
| 2018-06-30 | -$25.18M 10-Q · filed 2019-11-12 |
| 2018-03-31 | -$19.98M 10-Q · filed 2019-08-13 |
| 2017-12-31 | -$15.02M 10-K · filed 2021-03-30 |
| 2016-12-31 | -$6.20M 10-K · filed 2020-03-09 |
| 2015-12-31 | -$463.00K 10-K · filed 2019-03-13 |